Partnership Aims to Accelerate Innovation in Diagnostic Tools for Patients with Complex Tick and Vector-Borne Illnesses DURHAM, N.C., June 2nd, 2026, Galaxy Diagnostics, a leader in advanced vector-borne disease testing, has announced a strategic investment from Bay Area Lyme Ventures, the newly launched impact investment fund created by Bay Area Lyme Foundation to accelerate innovation… Continue reading Bay Area Lyme Ventures Invests in Galaxy Diagnostics to Advance Tick-Borne Disease Testing
By Edward B. Breitschwerdt, DVM, Co-Founder, Galaxy Diagnostics, and Distinguished Professor Emeritus of Internal Medicine and Infectious Diseases, NC State University College of Veterinary Medicine Summary: Bartonella is one of the most diagnostically overlooked pathogens in clinical medicine, not because it is rare, but because the standard tools used to find it (including both… Continue reading Bartonella: The Blind Spot Pathogen Clinicians Can’t Afford to Miss
Galaxy Diagnostics and Virginia Tech Unite to Advance Testing for Lyme Disease By Nicole Danielle Bell, CEO of Galaxy Diagnostics and author of What Lurks in the Woods When a Test Fails a Patient When diagnostics fail patients, the consequences are real. I’ve lived it. My husband tested negative using the current standard-of-care test for… Continue reading Two LymeX Innovators, One Mission: Better Answers for Patients
Galaxy Diagnostics and Virginia Tech Unite to Strengthen Direct Detection Approaches for Lyme Disease By Nicole Danielle Bell, CEO of Galaxy Diagnostics and author of What Lurks in the Woods The Diagnostic Uncertainty Clinicians Face Clinicians evaluating patients with suspected tick-borne disease routinely manage diagnostic uncertainty. Prior exposure, immune variability, and timing-dependent antibody responses can… Continue reading Two LymeX Innovators, One Mission: Advancing Reliable Lyme Diagnostics
By Jennifer C. Miller, PhD, Vice President of Clinical & Scientific Operations, Galaxy Diagnostics Summary: Babesia, Bartonella, and Borrelia are three of the most clinically important tick-borne pathogens in North America, while simultaneously being three of the most diagnostically elusive. Each has evolved distinct biological strategies to hide from the host immune system, suppress… Continue reading How Vector-Borne Pathogens Evade the Immune System
Navigating Nanotrap® testing for Lyme disease (Borrelia infection) with Sunjya Schweig, M.D.
